You are here: / Industry Press Releases

Centrillion Technologies Announces WeDoctor Partnership

July 31, 2018

PALO ALTO, CALIFORNIA – Centrillion Technologies, an innovator in building transformative genomic analysis tools announced that it has entered into a partnership with WeDoctor Holdings Limited (“WeDoctor”), China’s leading technology-enabled medical and healthcare solutions platform. The strategic cooperation agreement includes a multi-million US dollar investment by WeDoctor and establishes with Centrillion (Hangzhou) Co., Ltd. a joint [...]

Centrillion Taiwan Raises Financing from ARM IoT Fund

July 31, 2018

HSINCHU, TAIWAN– Centrillion Technologies Taiwan, an innovator in the development and commercialization of transformative genomic analysis tools announced today that it has received a strategic investment from the Arm IoT Fund. With this capital investment, Centrillion Taiwan will continue to expand its manufacturing subsidiary in Hsinchu, Taiwan.   As the largest chipset provider for big data, [...]

Mosflm processes EIGER data directly

July 31, 2018

Mosflm can now process EIGER data directly as HDF5. No conversion to CBF is required anymore. This will streamline processing and ensure that iMosflm's intuitive interface and clear output continue to see productive use. It also means that data processing can be done on Windows computers.   Processing of images read by Mosflm directly from [...]

Easier and more effective: MMI launches MMI CellTools 5.0

July 31, 2018

With the new software version, single cell isolation is now easier, more straight-forward and more precise than ever before.   MUNICH, Germany -- Today, MMI launched their latest development, the MMI CellTools 5.0 software platform. With more than 25 years of customer-focused innovation and continuous improvements, the software is now easier and more straight-forward to use. [...]

JH Technologies Welcomes Electron Microscope (EM) Sample Preparation Expert Jerome Pons

July 31, 2018

JH Technologies, leading distributor of optical and digital imaging systems, materials preparation, testing and analysis systems and metrology tools announces that Jerome Pons recently joined the company at its headquarters in Fremont, Calif. as senior imaging specialist. Mr. Pons brings nearly 20 years of experience in electron microscopy, including developing new techniques to improve efficiency [...]

Edstrom Industries and Triple Red Combine to Become Avidity Science™

July 31, 2018

WATERFORD, Wis.-- Today Edstrom Industries, LLC and its UK-based subsidiary Triple Red Limited, announce they will unify the company under the name Avidity Science.  The change is a key part of the company's strategic plan to build a diversified research solutions business which exceeds the product and service needs of scientists and healthcare customers around the [...]

Fluidic Analytics Secures US Patent Paving the Way for the Development and Commercialisation of Next-generation Protein Analysis Technology Platform

July 31, 2018

Cambridge, UK Fluidic Analytics Ltd, has announced the issuance of US Patent 9,952,22 B2, entitled ‘Fluidic Separation and Detection’, from the United States Patent and Trademark Office. This paves the way for the development and commercialisation of a next-generation protein analysis technology platform to be launched later this year. "The issuance of the US Patent [...]

ACEA Biosciences Introduces an Exploratory xCELLigence® RTCA S16 Instrument

July 31, 2018

The new 16-well model uses a proprietary noninvasive biosensor technology to quantify cell proliferation, morphology changes, and adhesion in a label-free, real-time manner. xCELLigence S16 SAN DIEGO ACEA Biosciences, is a privately owned biotechnology company which develops cutting edge instrumentation for cell analysis. The company has just introduced the xCELLigence RTCA S16, which the ideal [...]

William Muzek joins Lifecycle Biotechnologies as Business Development Manager

July 31, 2018

FORT WORTH, Texas Lifecycle Biotechnologies, a leading life science tools and services supplier, welcomes William “Will” Muzek as Business Development Manager. In this role, Mr. Muzek will lead the company-wide industrial strategic business development efforts to achieve strategic goals and to accelerate Lifecycle’s continued growth and expansion. With over 20 years in business development, Mr. [...]

Providing more affordable full-length single-cell mRNA sequencing with industry-leading coverage and sensitivity for in-depth cellular characterization SOUTH SAN FRANCISCO, Calif., July 31, 2018 (GLOBE NEWSWIRE) — Fluidigm Corporation, a leader in mass cytometry and microfluidics technologies, today announced a new full-length single-cell mRNA sequencing application for the C1™ system that provides deep coverage and high sensitivity while reducing sample preparation costs by over 30%. Ideal for validation and further interrogation of new single-cell populations identified by ultra-high throughput methods, this new application expands the capability of the C1 to advance new single-cell discoveries. Because ultra-high throughput methods currently lack the coverage and sensitivity to go beyond cell identification and classification, researchers in the single-cell community have increasingly relied on full-length sequencing to confirm and characterize newly identified single-cell populations. To support this approach, Fluidigm researchers collaborated with New England Biolabs® (NEB®) to develop a more affordable full-length single-cell mRNA sequencing workflow for use with C1. Researchers can easily upgrade their C1 systems and download the new NEBNext® full-length cDNA Synthesis scripts and protocols through Script Hub™ for immediate use with C1 96 mRNA sequencing and C1 Open App™ 96 integrated fluidic circuits. “NEB recently launched its NEBNext Single Cell/Low Input RNA Library Prep Kit, which enables high sensitivity and reliability of transcript detection, and is pleased to be working with Fluidigm to support its use on the C1 system,” said Fiona Stewart, Next Generation Sequencing Portfolio Manager at NEB. “Single-cell biology is an important and growing area of life science research, with great potential in many fields, including cancer and neurobiology. We are excited that the combination of NEB’s and Fluidigm’s technologies will better meet the needs of researchers working in this area.” “We are pleased to offer the single-cell community with a more cost-effective method to validate and characterize ultra-high throughput studies,” said Chris Linthwaite, President and CEO of Fluidigm. “By bringing together the advantages of microfluidics technology with optimized chemistries from NEB, we believe this winning combination will enable researchers to further expand our overall understanding of health and disease at single-cell resolution.” About Fluidigm Fluidigm (NASDAQ:FLDM) develops, manufactures, and markets life science analytical and preparatory systems for markets such as mass cytometry, high-throughput genomics, and single‑cell genomics. We sell to leading academic institutions, clinical research laboratories, and pharmaceutical, biotechnology, and agricultural biotechnology companies worldwide. Our systems are based on proprietary microfluidics and multiparameter mass cytometry technology and are designed to significantly simplify experimental workflow, increase throughput, and reduce costs while providing excellent data quality. Fluidigm products are provided for Research Use Only. Not for use in diagnostic procedures. We use our website (www.fluidigm.com), corporate Twitter account (@fluidigm), Facebook page (https://www.facebook.com/fluidigm), and LinkedIn page (https://www.linkedin.com/company/fluidigm-corporation) as channels of distribution of information about our products, our planned financial and other announcements, our attendance at upcoming investor and industry conferences, and other matters. Such information may be deemed material information, and we may use these channels to comply with our disclosure obligations under Regulation FD. Therefore, investors should monitor our website and our social media accounts in addition to following our press releases, SEC filings, public conference calls, and webcasts. Fluidigm, the Fluidigm logo, C1, C1 Open App, and Script Hub are trademarks and/or registered trademarks of Fluidigm Corporation in the United States and/or other countries. All other trademarks are the sole property of their respective owners. Forward-Looking Statement for Fluidigm This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including, among others, statements regarding the anticipated benefits of newly introduced products and the growth and potential of single-cell biology research. Forward-looking statements are subject to numerous risks and uncertainties that could cause actual results to differ materially from currently anticipated results, including but not limited to risks relating to challenges inherent in developing, manufacturing, launching, marketing, and selling new products; potential product performance and quality issues; intellectual property risks; and competition. Information on these and additional risks and uncertainties and other information affecting Fluidigm business and operating results is contained in Fluidigm’s Annual Report on Form 10-K for the year ended December 31, 2017, and in its other filings with the Securities and Exchange Commission, including the Fluidigm Quarterly Report on Form 10-Q for the quarter ended March 31, 2018. These forward-looking statements speak only as of the date hereof. Fluidigm disclaims any obligation to update these forward-looking statements except as may be required by law.

July 31, 2018

Didier Hirsch to Retire Oct. 31 Robert W. McMahon to Become Chief Financial Officer SANTA CLARA, Calif-- Agilent Technologies Inc. (NYSE:A) today announced that Didier Hirsch, senior vice president and chief financial officer, has decided to retire on Oct 31, 2018. The company has appointed Robert W. McMahon, currently chief financial officer, Hologic, Inc., as his successor. McMahon will join Agilenton August 3, as senior vice [...]

Access IBO on Knowledge Center